SCHEMBL21855207

SCHEMBL21855207

CN1CCN([C@H]2CCCN(c3cnc(C#N)c(Nc4ccc(C(=O)O)cc4)n3)C2)C1=O

nearest known ligand 0.64

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 19/20 0.64
▸ LCK P06239 18/20 0.64
▸ BTK Q06187 4/20 0.64
▸ EGFR P00533 10/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28639751 1.00 JAK3 (0.64) JAK3LCKBTKEGFR
SCHEMBL28639750 1.00 JAK3 (0.64) JAK3LCKBTKEGFR
SCHEMBL28638122 0.92 JAK3 (0.60) JAK3LCKBTKEGFR
SCHEMBL21946358 0.92 JAK3 (0.60) JAK3LCKBTKEGFR
SCHEMBL30010753 0.92 JAK3 (0.60) JAK3LCKBTKEGFR
SCHEMBL21855138 0.89 JAK3 (0.62) JAK3LCKBTKEGFR
SCHEMBL21855180 0.88 JAK3 (0.60) JAK3LCKBTKEGFR
SCHEMBL21855194 0.88 JAK3 (0.65) JAK3LCKBTKEGFR
SCHEMBL25605299 0.87 JAK3 (0.58) JAK3LCKBTKEGFR
SCHEMBL21855142 0.86 JAK3 (0.57) JAK3LCKBTKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081450-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2020-04-23 — — WO disclosed
Send feedback